share_log

Why Hainan Haiyao's (SZSE:000566) Earnings Are Better Than They Seem

Why Hainan Haiyao's (SZSE:000566) Earnings Are Better Than They Seem

为什么海南海药(SZSE: 000566)的收益好于预期
Simply Wall St ·  2023/04/17 04:21

Hainan Haiyao Co., Ltd.'s (SZSE:000566) solid earnings announcement recently didn't do much to the stock price. Our analysis suggests that shareholders might be missing some positive underlying factors in the earnings report.

海南海药股份有限公司's (SZSE: 000566) 最近公布的稳健财报并没有对股价产生太大影响。我们的分析表明,股东在收益报告中可能缺少一些积极的潜在因素。

Check out our latest analysis for Hainan Haiyao

看看我们对海南海药的最新分析

earnings-and-revenue-history
SZSE:000566 Earnings and Revenue History April 17th 2023
深交所:000566 收益和收入历史记录 2023 年 4 月 17 日

How Do Unusual Items Influence Profit?

不寻常的物品如何影响利润?

For anyone who wants to understand Hainan Haiyao's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥15m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hainan Haiyao to produce a higher profit next year, all else being equal.

对于任何想了解海南海药在法定数字之外的利润的人来说,值得注意的是,在过去的十二个月中,由于不寻常的项目,法定利润减少了1500万元人民币。尽管由于不寻常物品而产生的扣除额一开始令人失望,但有一线希望。我们调查了数千家上市公司,发现不寻常的物品本质上往往是一次性的。而且,毕竟,这正是会计术语所暗示的。因此,假设这些不寻常的支出不会再次出现,那么在其他条件相同的情况下,我们预计海南海药明年将产生更高的利润。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hainan Haiyao.

注意: 我们始终建议投资者检查资产负债表的实力。点击此处查看我们对海南海药的资产负债表分析。

Our Take On Hainan Haiyao's Profit Performance

我们对海南海药盈利表现的看法

Unusual items (expenses) detracted from Hainan Haiyao's earnings over the last year, but we might see an improvement next year. Because of this, we think Hainan Haiyao's earnings potential is at least as good as it seems, and maybe even better! And one can definitely find a positive in the fact that it made a profit this year, despite losing money last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Case in point: We've spotted 2 warning signs for Hainan Haiyao you should be mindful of and 1 of these makes us a bit uncomfortable.

不寻常的项目(支出)减少了海南海药去年的收益,但明年我们可能会看到改善。正因为如此,我们认为海南海药的盈利潜力至少和看起来一样好,甚至可能更好!尽管去年亏损,但它今年还是实现了盈利,这一事实绝对可以从中找到积极的一面。当然,在分析其收益时,我们只是浮出水面;人们也可以考虑利润率、预测增长和投资回报率等因素。有鉴于此,如果你想对公司进行更多分析,了解所涉及的风险至关重要。一个很好的例子:我们发现了 海南海药有 2 个警告信号 你应该注意,其中之一让我们有点不舒服。

This note has only looked at a single factor that sheds light on the nature of Hainan Haiyao's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

这份报告只着眼于一个揭示海南海药利润性质的单一因素。但是,还有很多其他方法可以告知你对公司的看法。有些人认为高股本回报率是业务质量的好兆头。虽然可能需要代表你做一些研究,但你可能会发现这一点 免费的 一系列拥有高股本回报率的公司,或者这份内部人士为了有用而买入的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧? 取得联系 直接和我们联系。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是一般性的。 我们仅使用不偏不倚的方法根据历史数据和分析师预测提供评论,我们的文章并非旨在提供财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能未将最新的价格敏感型公司公告或定性材料考虑在内。简而言之,华尔街对上述任何股票都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发